Merck & Co. ٢١ مايو ٢٠٢٦ ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer - Fierce Pharma
Merck & Co. ٢٠ مايو ٢٠٢٦ EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study - TradingView
Merck & Co. ١٩ مايو ٢٠٢٦ Merck inks Keytruda supply pact to support Exelixis cancer trial - Fierce Biotech
Merck & Co. ١٨ مايو ٢٠٢٦ Results Reinforce Merck/Kelun’s Sac-TMT As Major TROP2 Player - Citeline News & Insights
Merck & Co. ١٨ مايو ٢٠٢٦ Merck ADC, licensed from China, hits mark in first big global trial - BioPharma Dive
Merck & Co. ١٨ مايو ٢٠٢٦ Merck & Co.'s first pivotal study of sac-TMT comes up trumps - FirstWord Pharma
Merck & Co. ١٨ مايو ٢٠٢٦ Microbiotica Announces Positive Results from its Phase 1b Trial (MELODY-1) of MB097, a Precision Microbiome Co-Therapy in Advanced Melanoma - The Manila Times
Merck & Co. ١٦ مايو ٢٠٢٦ Merck & Co., Inc. stock (US58933Y1055): Keytruda momentum and fresh earnings keep big pharma in focu - AD HOC NEWS
Merck & Co. ١٥ مايو ٢٠٢٦ Merck & Co., Inc. stock (US58933Y1055): pharma giant doubles down on M&A as investors eye post-Keytr - AD HOC NEWS
Merck & Co. ١٤ مايو ٢٠٢٦ AstraZeneca scores with Imfinzi in another bladder cancer trial, rivaling Merck's Keytruda - Fierce Pharma
Merck & Co. ١٤ مايو ٢٠٢٦ Merck & Co., Inc. stock (US58933Y1055): Latest developments and business overview - AD HOC NEWS
Merck & Co. ١٣ مايو ٢٠٢٦ Cortisone Shots Market 2026 | Merck & Co, Pfizer, Bristol-Myers Squibb, Novartis, Pharmascience etc. - openPR.com
Merck & Co. ١٢ مايو ٢٠٢٦ Merck & Co. stock (US58933Y1055): Oncology portfolio advances at ASCO 2026 - AD HOC NEWS
Merck & Co. ١٢ مايو ٢٠٢٦ Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma - The Manila Times
Merck & Co. ١٢ مايو ٢٠٢٦ Erasca partners with Merck on best-in-class pan-RAS molecular glue - The Pharma Letter
Merck & Co. ١١ مايو ٢٠٢٦ Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Merck & Co. ١١ مايو ٢٠٢٦ Merck makes a new move in Astra battle | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Merck & Co. ١١ مايو ٢٠٢٦ Amid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase data - Fierce Biotech